Theriva Biologics, Inc. (TOVX)
0.251
0.00 (0.00%)
USD |
NYAM |
Sep 02, 16:00
0.251
0.00 (0.00%)
After-Hours: 19:41
Theriva Biologics Net Income (TTM) : -11.62M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -11.62M |
| March 31, 2026 | -21.46M |
| December 31, 2025 | -23.74M |
| September 30, 2025 | -26.19M |
| June 30, 2025 | -29.56M |
| March 31, 2025 | -24.81M |
| December 31, 2024 | -25.65M |
| September 30, 2024 | -26.69M |
| June 30, 2024 | -22.27M |
| March 31, 2024 | -19.04M |
| December 31, 2023 | -18.35M |
| September 30, 2023 | -18.46M |
| June 30, 2023 | -19.98M |
| March 31, 2023 | -19.38M |
| December 31, 2022 | -19.17M |
| September 30, 2022 | -18.84M |
| June 30, 2022 | -17.29M |
| March 31, 2022 | -16.00M |
| December 31, 2021 | -14.27M |
| September 30, 2021 | -11.14M |
| June 30, 2021 | -9.975M |
| March 31, 2021 | -9.663M |
| December 31, 2020 | -10.12M |
| September 30, 2020 | -11.13M |
| June 30, 2020 | -14.17M |
| Date | Value |
|---|---|
| March 31, 2020 | -14.84M |
| December 31, 2019 | -15.38M |
| September 30, 2019 | -15.43M |
| June 30, 2019 | -13.97M |
| March 31, 2019 | -14.62M |
| December 31, 2018 | -13.42M |
| September 30, 2018 | -7.417M |
| June 30, 2018 | -14.66M |
| March 31, 2018 | -14.76M |
| December 31, 2017 | -15.49M |
| September 30, 2017 | -20.78M |
| June 30, 2017 | -18.33M |
| March 31, 2017 | -19.78M |
| December 31, 2016 | -27.80M |
| September 30, 2016 | -36.63M |
| June 30, 2016 | -35.65M |
| March 31, 2016 | -43.50M |
| December 31, 2015 | -44.78M |
| September 30, 2015 | -39.97M |
| June 30, 2015 | -37.37M |
| March 31, 2015 | -28.30M |
| December 31, 2014 | -19.78M |
| September 30, 2014 | -17.53M |
| June 30, 2014 | -15.99M |
| March 31, 2014 | -13.93M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 129.87M |
| Nkarta, Inc. | -117.32M |
| Unicycive Therapeutics, Inc. | -35.22M |
| OnKure Therapeutics, Inc. | -58.70M |
| ACADIA Pharmaceuticals, Inc. | 380.48M |